Peptide Synthesis Market Size, Share, Growth Analysis, By Product (Equipment, Peptide Synthesizers), By Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis), By Application (Personalized Therapeutics, Cancer, Metabolic), By End-use, By Region - Industry Forecast 2024-2031.

Drivers

Growing Demand for Imaging Based Diagnosis

• Imaging technology demand is growing substantially for accurate diagnosis of chronic diseases. Peptide synthesis market was valued at more than USD 30 billion in 2023. Use of biosensors and biomarkers for both invasive and non-invasive diagnosis is also very prevalent. Peptide based biosensors and biomarkers are experiencing massive demand growth fueling the market for peptide synthesis.

Increasing Acceptance of Personalized Medicine and Therapeutics

• Healthcare expenditure is increasing significantly in developed economies in North America and Europe. Due to the higher healthcare expenditure, the acceptance of more expensive alternate treatments such as personalized medicine is growing. Peptide based personalized medicine and therapeutics solutions are expected to gain momentum and drive the market demand during the forecast period.

Restraints

Lack of Standardization

• Pharmaceutical companies are spending significant resources on the development of peptide based therapeutic products, but the manufacturing is predominantly managed by contract manufacturing companies. Most of these contract manufacturing companies operate out of developed economies due to the low cost of production and does to adhere to the standardization guidelines or to the safety standards.

Strict Regulatory Framework

• Pharmaceutical companies on average spent an upwards of USD 50 million on development, clinical trial and approval process for a drug or therapeutic solution as the regulations are very strict and adhering to those is cost intensive. This has caused an entry barrier to many companies, and peptide-based solutions have become expensive for the end users.